Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Smooth Endoplasmic Reticulum01:21

Smooth Endoplasmic Reticulum

6.2K
Smooth endoplasmic reticulum or smooth ER is a sub-organelle with specialized functions in animal cells and plant cells. It is often associated with the tubule morphology of the endoplasmic reticulum.
The ER provides optimal conditions for synthesizing steroid hormones and lipids, such as phospholipids and triglycerides. Traditionally, lipid metabolism was considered to be a smooth ER function. However, there is no direct evidence to prove that rough ER is completely excluded from lipid...
6.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Not all acute peripheral facial palsy in children recovers completely: A telediagnostic follow-up study.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society·2026
Same author

Acute changes in gait biomechanics in children with cerebral palsy due to barefoot vs. footwear condition - An exploratory study.

Clinical biomechanics (Bristol, Avon)·2026
Same author

Serum neurofilament light chain in paediatric patients treated with natalizumab for highly active multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same author

Artificial Liver Support Effectively Removes Immunosuppressive Bile Acids From Circulation in Patients With Severe Liver Failure: A Proof of Concept Study.

Critical care explorations·2026
Same author

Quantitative analysis of murine C-terminal alpha-1-antitrypsin peptides in experimental sepsis and their comparison with human sepsis peptide biomarkers.

Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals·2026
Same author

Immune-metabolic trajectories delineate subgroups in paediatric long COVID.

Nature communications·2026

Related Experiment Video

Updated: Sep 10, 2025

An Electrochemiluminescence-Based Assay for MeCP2 Protein Variants
07:44

An Electrochemiluminescence-Based Assay for MeCP2 Protein Variants

Published on: May 22, 2020

27.5K

Rett Syndrome: Specific MECP2 Variants are Associated With Elevated Serum Neurofilament Light Chain.

Emma Hirn1, Brenda Huppke1, Bernd Wilken2

  • 1Department of Neuropediatrics, Jena University Hospital, Jena, Germany.

Pediatric Neurology
|August 22, 2025
PubMed
Summary

Serum neurofilament light chain (sNfL) levels are elevated in some Rett syndrome patients, indicating neuronal damage. This elevation is linked to specific severe MECP2 variants, suggesting sNfL as a biomarker for future therapies.

Keywords:
MECP2Methyl CpG binding protein 2 variantsRett syndromeSerum neurofilament light chains

More Related Videos

A Non-random Mouse Model for Pharmacological Reactivation of Mecp2 on the Inactive X Chromosome
08:27

A Non-random Mouse Model for Pharmacological Reactivation of Mecp2 on the Inactive X Chromosome

Published on: May 22, 2019

6.5K
A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
08:22

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations

Published on: December 1, 2017

8.7K

Related Experiment Videos

Last Updated: Sep 10, 2025

An Electrochemiluminescence-Based Assay for MeCP2 Protein Variants
07:44

An Electrochemiluminescence-Based Assay for MeCP2 Protein Variants

Published on: May 22, 2020

27.5K
A Non-random Mouse Model for Pharmacological Reactivation of Mecp2 on the Inactive X Chromosome
08:27

A Non-random Mouse Model for Pharmacological Reactivation of Mecp2 on the Inactive X Chromosome

Published on: May 22, 2019

6.5K
A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
08:22

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations

Published on: December 1, 2017

8.7K

Area of Science:

  • Neuroscience
  • Genetics
  • Biomarker Research

Background:

  • Rett syndrome is a neurodevelopmental disorder in females caused by MECP2 variants.
  • Clinical decline in Rett syndrome suggests neuronal damage, but pathology studies have not confirmed neurodegeneration.
  • Serum neurofilament light chain (sNfL) is a sensitive biomarker for neuronal damage.

Purpose of the Study:

  • To investigate neurodegeneration in Rett syndrome by measuring sNfL levels.
  • To correlate sNfL levels with MECP2 variant type and clinical severity.

Main Methods:

  • Cross-sectional study of 77 females with confirmed pathogenic MECP2 variants.
  • sNfL levels measured via single-molecule array assay.
  • sNfL levels converted to age-adjusted z-scores and compared with variant type and clinical data.

Main Results:

  • Rett syndrome cohort showed significantly higher sNfL z-scores than healthy controls (P < 0.001).
  • Elevated sNfL z-scores were specifically associated with pathogenic variants in the nuclear receptor corepressor interaction domain (P < 0.001).
  • Patients with severe motor and hand function impairment had higher sNfL levels (P = 0.04).

Conclusions:

  • sNfL levels indicate ongoing neuronal damage in a subset of Rett syndrome patients.
  • Elevated sNfL is primarily linked to severe pathogenic MECP2 variants affecting a specific domain.
  • sNfL shows potential as a biomarker for monitoring disease progression and therapeutic efficacy in Rett syndrome.